ANAB
AnaptysBio Inc
NASDAQ: ANAB · HEALTHCARE · BIOTECHNOLOGY
$62.34
-5.70% today
Updated 2026-04-29
Market cap
$1.81B
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$11 – $72
Volume
0.6M
AnaptysBio Inc (ANAB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.48M | $15.84M | $17.57M | $16.68M | $10.00M | $5.00M | $8.00M | $75.00M | $63.17M | $10.29M | $17.16M | $91.28M | $234.60M |
| Revenue growth (YoY) | — | +188.9% | +10.9% | -5.0% | -40.1% | -50.0% | +60.0% | +837.5% | -15.8% | -83.7% | +66.8% | +432.0% | +157.0% |
| Cost of revenue | $8.82M | $8.61M | $17.30M | $15.42M | $29.44M | $56.20M | $99.34M | $80.03M | $98.50M | $88.80M | $132.28M | $163.84M | $2.42M |
| Gross profit | $-3.34M | $7.22M | $267000.00 | $1.26M | $-19.44M | $-51.20M | $-91.34M | $-5.03M | $-35.32M | $-78.51M | $-115.13M | $-72.56M | $232.18M |
| Gross margin | -60.9% | 45.6% | 1.5% | 7.6% | -194.4% | -1023.9% | -1141.7% | -6.7% | -55.9% | -763.2% | -671.0% | -79.5% | 99.0% |
| R&D | $8.82M | $8.61M | $17.30M | $22.62M | $30.94M | $56.30M | $99.34M | $80.03M | $98.50M | $88.80M | $139.62M | $163.84M | $135.97M |
| SG&A | $1.95M | $2.35M | $3.59M | $4.29M | $9.34M | $15.53M | $16.09M | $18.85M | $21.49M | $36.64M | $41.95M | $42.39M | $50.74M |
| Operating income | $-5.29M | $4.87M | $-3.32M | $-3.02M | $-28.78M | $-66.72M | $-107.43M | $-23.88M | $-56.81M | $-115.15M | $-164.41M | $-114.95M | $47.90M |
| Operating margin | -96.4% | 30.7% | -18.9% | -18.1% | -287.8% | -1334.4% | -1342.9% | -31.8% | -89.9% | -1119.4% | -958.3% | -125.9% | 20.4% |
| EBITDA | $-4.08M | $5.12M | $-4.53M | $-3.57M | $-28.11M | $-59.88M | $-95.93M | $-19.37M | $-55.71M | $-105.26M | $-156.42M | $-92.74M | $50.32M |
| EBITDA margin | -74.4% | 32.3% | -25.8% | -21.4% | -281.1% | -1197.6% | -1199.2% | -25.8% | -88.2% | -1023.2% | -911.7% | -101.6% | 21.4% |
| EBIT | $-4.66M | $4.81M | $-4.81M | $-3.80M | $-28.30M | $-60.20M | $-96.45M | $-19.93M | $-57.80M | $-107.59M | $-157.07M | $-95.14M | $47.90M |
| Interest expense | $886000.00 | $1.28M | $460000.00 | $458000.00 | $1.77M | $1.65M | $1.04M | $3.96M | $1.45M | $21.11M | $18.08M | $50.09M | $79.89M |
| Income tax | $887000.00 | $1.28M | $139000.00 | $205000.00 | $1.82M | $-192000.00 | $-152000.00 | $-11000.00 | $-603000.00 | $24000.00 | $-4000.00 | $3000.00 | — |
| Effective tax rate | -19.0% | 84.7% | -2.6% | -5.1% | -6.4% | 0.3% | 0.2% | 0.1% | 1.0% | -0.0% | 0.0% | -0.0% | 0.0% |
| Net income | $-5.54M | $232000.00 | $-5.41M | $-4.26M | $-30.07M | $-61.66M | $-97.34M | $-19.93M | $-57.80M | $-128.72M | $-163.62M | $-145.23M | $-13.23M |
| Net income growth (YoY) | — | +104.2% | -2429.7% | +21.2% | -606.0% | -105.0% | -57.9% | +79.5% | -190.0% | -122.7% | -27.1% | +11.2% | +90.9% |
| Profit margin | -101.1% | 1.5% | -30.8% | -25.5% | -300.7% | -1233.1% | -1216.7% | -26.6% | -91.5% | -1251.3% | -953.7% | -159.1% | -5.6% |